Updates on juvenile dermatomyositis from the last decade: classification to outcomes
H Kim, AM Huber, S Kim - Rheumatic Disease Clinics, 2021 - rheumatic.theclinics.com
Juvenile dermatomyositis (JDM) is a rare heterogeneous immune-medicated condition with
characteristic skin rashes, muscle weakness, vasculopathy, and other organ involvement …
characteristic skin rashes, muscle weakness, vasculopathy, and other organ involvement …
Update on biomarkers of vasculopathy in juvenile and adult myositis
K McLellan, C Papadopoulou - Current Rheumatology Reports, 2022 - Springer
Abstract Purpose of Review Although rare, idiopathic inflammatory myopathies (IIM)
comprise a heterogeneous group of autoimmune conditions in adults and children …
comprise a heterogeneous group of autoimmune conditions in adults and children …
Identification of common mechanisms and biomarkers for dermatomyositis and atherosclerosis based on bioinformatics analysis
Y Ma, J Lai, Q Wan, Z Chen, L Sun… - Skin Research and …, 2024 - Wiley Online Library
Background Dermatomyositis (DM) manifests as an autoimmune and inflammatory
condition, clinically characterized by subacute progressive proximal muscle weakness …
condition, clinically characterized by subacute progressive proximal muscle weakness …
T cell interaction with activated endothelial cells primes for tissue-residency
J Wienke, SR Veldkamp, EM Struijf… - Frontiers in …, 2022 - frontiersin.org
Tissue-resident memory T cells (TRM) are suspected drivers of chronic inflammation, but
their induction remains unclear. Since endothelial cells (EC) are obligate interaction …
their induction remains unclear. Since endothelial cells (EC) are obligate interaction …
[HTML][HTML] Flow Mediated Dilation in Systemic Sclerosis: Association with clinical findings, capillaroscopic patterns and endothelial circulating markers
A Corrado, N Mansueto, M Correale, V Rella… - Vascular …, 2024 - Elsevier
Aim Endothelial dysfunction represents a key feature of the pathological process underlying
micro and macro-vascular damage in Systemic Sclerosis (SSc). This study aims to improve …
micro and macro-vascular damage in Systemic Sclerosis (SSc). This study aims to improve …
Baicalin inhibited both the Furin/TGFβ1/Smad3/TSP-1 pathway in endothelial cells and the AKT/Ca2+/ROS pathway in platelets to ameliorate inflammatory …
P Wang, J Wu, Q Wang, S Zhuang, J Zhao, Y Yu… - European Journal of …, 2023 - Elsevier
Inflammatory coagulopathy is resulted from endothelial dysfunction and platelet
hyperactivation in inflammatory diseases. In this study, the effects of baicalin, an active …
hyperactivation in inflammatory diseases. In this study, the effects of baicalin, an active …
Perivascular and endomysial macrophages expressing VEGF and CXCL12 promote angiogenesis in anti-HMGCR immune-mediated necrotizing myopathy
A Lia, T Annese, M Fornaro, M Giannini… - …, 2022 - academic.oup.com
Objectives To study the phenotype of macrophage infiltrates and their role in angiogenesis
in different idiopathic inflammatory myopathies (IIMs). Methods The density and distribution …
in different idiopathic inflammatory myopathies (IIMs). Methods The density and distribution …
Circulating markers of inflammation and angiogenesis and clinical outcomes across subtypes of pulmonary arterial hypertension
K Hirsch, S Nolley, DD Ralph, Y Zheng… - The Journal of Heart and …, 2023 - Elsevier
Background Subtypes of pulmonary arterial hypertension (PAH) differ in both fundamental
disease features and clinical outcomes. Angiogenesis and inflammation represent disease …
disease features and clinical outcomes. Angiogenesis and inflammation represent disease …
[HTML][HTML] Inflammatory markers in cerebrospinal fluid of paediatric spinal muscular atrophy patients receiving nusinersen treatment
FEV Scheijmans, I Cuppen, MM Zwartkruis… - European Journal of …, 2023 - Elsevier
Spinal muscular atrophy (SMA) is a progressive motor neuron disease with onset during
infancy or early childhood. Recent therapeutic advances targeting the genetic defect that …
infancy or early childhood. Recent therapeutic advances targeting the genetic defect that …
Comparison of cytokine/chemokine profiles between dermatomyositis and anti-synthetase syndrome
Y Wang, Y Zheng, Y Zhao, Y Liu, W Zhang… - Frontiers in …, 2022 - frontiersin.org
Objectives Dermatomyositis (DM) and anti-synthetase syndrome (ASS) are autoimmune
diseases with multisystem involvement. Despite sharing some clinical and myopathological …
diseases with multisystem involvement. Despite sharing some clinical and myopathological …